Earnings season kicks into high gear next week, with a slate of heavyweight companies set to report quarterly results between July 12 and July 18. As investors look for fresh insight into corporate earnings, guidance and the broader economic backdrop, options traders are already betting on how sharply these stocks could move once the numbers are released.
The options market is pricing in significant post-earnings volatility across sectors ranging from banking and healthcare to semiconductors and streaming, setting the stage for a week that could generate some of the biggest single-stock moves of the quarter.
JPMorgan Opens Earnings Week
JPMorgan Chase & Co. (NYSE:JPM) reports second-quarter 2026 results Tuesday before the opening bell. Analysts expect $5.59 in EPS on $49.39 billion in revenue, up from $4.96 on $45.68 billion a year ago.
Benzinga Pro data show options pricing in a 3.87% move — the smallest on this list — which still equates to $34.9 billion of market value at stake given JPMorgan’s $903 billion market cap.
JPMorgan runs one of the world’s largest financial platforms, with a $4.9 trillion balance sheet and $2.68 trillion in deposits as of March. The stock holds a Buy consensus rating and trades above its average price forecast. In July, both B of A Securities and UBS reiterated Buy ratings and raised their targets.
Shares are up 3.4% year-to-date in 2026, trading 9.0% above the 200-day moving average and within 1.9% of the 52-week high of $343.45.
Johnson & Johnson — Healthcare Earnings Spotlight
Johnson & Johnson (NYSE:JNJ) reports second-quarter 2026 results Wednesday before the opening bell. Consensus estimates call for $2.85 in EPS on $25.05 billion in revenue, compared with $2.77 on $23.74 billion a year earlier.
The options market is pricing in a 4.13% move, according to Benzinga Pro — about $25.8 billion of market value at stake as investors weigh how the quarter lands across the company’s two remaining business pillars.
J&J is now a pure-play across innovative medicine and medtech following its 2023 consumer-health spinoff. The stock holds a Buy consensus rating and trades above its price forecast. Morgan Stanley and Citigroup both reiterated bullish ratings in July while raising their targets.
Shares are up 24.6% year-to-date in 2026, trading 17.2% above the 200-day moving average and about 68% above the 52-week low of $154.21.
GE Tests Aerospace Demand
GE Aerospace (NYSE:GE) reports second-quarter 2026 results Thursday before the opening bell. Analysts expect $1.85 in EPS on $11.79 billion in revenue, versus $1.66 on $11.02 billion a year ago.
Options are pricing in a 5.89% move, putting roughly $22 billion of market value at stake. For a company tied closely to commercial engine demand and servicing trends, that signals the market expects a meaningful reaction to both results and forward guidance.
GE Aerospace designs, manufactures, and services commercial aircraft turbine engines, including through its CFM joint venture with Safran. The stock carries a Buy consensus rating and trades above its average price forecast. Susquehanna, Jefferies and Citigroup all raised their price forecasts in July.
Shares are up 11.1% year-to-date in 2026, trading 14.8% above the 200-day moving average and about 47% above the 52-week low of $243.34.
UnitedHealth Group
UnitedHealth Group Incorporated (NYSE:UNH) reports second-quarter 2026 results Thursday before the opening bell. Consensus calls for $4.85 in EPS on $110.77 billion in revenue, compared with $4.08 on $111.62 billion a year ago.
Benzinga Pro shows a 6.06% implied move, with $23.5 billion of market value at stake. The setup stands out because revenue is expected to dip slightly year-over-year even as EPS rises — a mix that could sharpen focus on medical-cost trends this quarter.
UnitedHealth is one of the largest private health insurers globally, covering about 51 million members as of December 2025. The stock carries a Buy consensus rating and trades above its average price forecast. RBC Capital reiterated Outperform and raised its target in July, while HSBC reiterated Hold and also raised its forecast.
Shares are up 26.8% year-to-date in 2026, trading 25.8% above the 200-day moving average and within 1.7% of the 52-week high of $434.30.
TSMC Leads Market Movers
Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM) reports second-quarter 2026 results Thursday before the opening bell. Wall Street is modeling $3.77 in earnings per share on $39.76 billion in revenue, up sharply from $2.47 on $30.07 billion a year ago.
Options are pricing in a 6.65% move, according to Benzinga Pro — and at this size, the dollar stakes are enormous: roughly $150 billion of market value hangs in the balance. That’s a swing large enough to ripple across the broader semiconductor supply chain, given TSMC’s central role in it.
TSMC is the world’s largest dedicated chip foundry, holding roughly 70% market share in 2025. The stock carries a Buy consensus rating, though shares trade below the average analyst price forecast. In June, both B of A Securities and Susquehanna raised their price forecasts.
Shares have rallied 35.6% year-to-date in 2026 and trade 24.7% above the 200-day moving average, sitting about 94% above their 52-week low of $223.70.
Netflix Faces Growth Test
Netflix Inc. (NASDAQ:NFLX) reports second-quarter 2026 results Thursday after the closing bell. Consensus calls for 79 cents in EPS on $12.58 billion in revenue, compared with 72 cents on $11.08 billion a year earlier.
Options imply a 7.20% move, according to Benzinga Pro, putting about $22.1 billion of market value at stake. Netflix earnings often function as a referendum on streaming momentum and forward guidance, which can amplify the post-close reaction.
Netflix runs a single core streaming business with more than 300 million subscribers globally. The stock carries a Buy consensus rating, though shares trade well below the average price forecast. Citigroup reiterated Buy in July while cutting its target,and Bernstein reiterated Outperform while also lowering its target.
Shares have pulled back 19.4% year-to-date in 2026, trading 23.1% below the 200-day moving average and within 3% of the 52-week low of $70.86.
Intuitive Surgical Faces Test
Intuitive Surgical Inc. (NASDAQ:ISRG) reports second-quarter 2026 results Thursday after the closing bell. The Street expects $2.41 in EPS on $2.82 billion in revenue, up from $2.19 on $2.44 billion a year ago.
Options traders are braced for a 7.91% move, per Benzinga Pro, with about $11.6 billion of market value at stake — a sizable implied swing for a large-cap medtech name, and one that arrives as the stock has lagged this group on a year-to-date basis.
Intuitive Surgical develops robotic systems for minimally invasive surgery and generates recurring revenue from instruments, accessories, and services. The stock carries a Buy consensus rating, with the average price forecast sitting well above the current share price. BMO Capital initiated coverage in July with an Outperform rating, while Evercore ISI reiterated In-Line and trimmed its price forecast.
Shares have pulled back 27.5% year-to-date in 2026, trading 15.1% below the 200-day moving average and within 4.5% of the 52-week low of $396.68.
ASML’s Biggest Volatility Bet
ASML Holding NV (NASDAQ:ASML) reports second-quarter 2026 results Wednesday before the opening bell. Consensus estimates call for $7.98 in EPS on $10.28 billion in revenue, versus $6.69 on $8.72 billion in the year-ago quarter.
Options traders are bracing for an 8.64% move — the widest implied swing on this list — putting roughly $60.2 billion of market value at stake. That range underscores how closely ASML’s results and commentary are tied to broader semiconductor-capex expectations.
ASML is the dominant name in lithography systems used to manufacture chips, commanding about 90% market share. The stock carries a Strong Buy consensus rating, though shares trade above the average price forecast. Bernstein reiterated an Outperform rating in July while raising its price forecast and Wells Fargo reiterated Overweight in June while doing the same.
Shares have surged 53.6% year-to-date in 2026, trading 34.2% above the 200-day moving average and about 162% above the 52-week low of $683.48.
| Company | Implied Move | Estimated Value at Stake | Market Cap |
|---|---|---|---|
| ASML Holding (ASML) | 8.64% | $60.2B | $696B |
| Intuitive Surgical (ISRG) | 7.91% | $11.6B | $147B |
| Netflix (NFLX) | 7.20% | $22.1B | $307B |
| Taiwan Semiconductor (TSM) | 6.65% | $150B | $2.30T |
| UnitedHealth Group (UNH) | 6.06% | $23.5B | $388B |
| GE Aerospace (GE) | 5.89% | $22.0B | $373B |
| Johnson & Johnson (JNJ) | 4.13% | $25.8B | $624B |
| JPMorgan Chase (JPM) | 3.87% | $34.9B | $903B |
Image via Shutterstock
Login to comment